DEFA14A ·Filed Mar 19, 2026

VCEL

Vericel Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001308179-26-000095
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard annual governance filing with no immediate trading implications. Traders should monitor for any unexpected changes in the board nominees or compensation packages, which could signal internal shifts, but none are indicated in this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VCEL ▲ +14.42% at T+60d
NEUTRAL call ✓ call won +14.42% · α vs SPY +0.07% · entry $32.74 → $37.46
Entry anchored
Mar 18, 03:59 PM ET
via exchange tick
T+1d
-4.06%
call -4.06% · α -2.32%
$31.41
settled 7mo ago
T+5d
-5.86%
call -5.86% · α -3.65%
$30.82
settled 6mo ago
T+20d
+8.98%
call +8.98% · α +1.36%
$35.68
settled 6mo ago
T+60d
+14.42%
call +14.42% · α +0.07%
$37.46
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Vericel Corp (VCEL) filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Shareholders. The filing outlines three key proposals: the election of seven director nominees, an advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the company's independent auditor. The filing is routine and was submitted by the company itself.

Key Facts

  • The filing is a DEFA14A, a definitive proxy statement for the 2026 Annual Meeting.
  • The proposals include the election of 7 directors, an advisory vote on executive pay, and ratification of the auditor.
  • The filing was made by the company (Vericel Corp), not by an activist or dissident party.
  • The meeting will be held virtually on April 29, 2026.

Financial Impact

No direct financial impact. This is a routine governance filing.

Risk Factors

  • Routine filing risk: The filing itself carries no material risk.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001308179-26-000095
Document: 0001308179-26-000095-index-headers.html0001308179-26-000095
Document: 0001308179-26-000095-index.html0001308179-26-000095
Document: 0001308179-26-000095.txt0001308179-26-000095
12 reports for VCEL
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+60▲ +31.08%May 7, 2026
Filters
Rows
Reports for VCEL — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$45.36 $40.89▼ −9.85%▼ −9.25%$39.91 (−12.01%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 6/10
$47.61 $41.18▼ −13.51%▼ −17.47%$39.91 (−16.17%)
Jul 16, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$47.81 $44.54▼ −6.84%▼ −10.46%$39.91 (−16.52%)
Jun 30, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$45.15 $46.62▲ +3.26%▲ +5.44%$39.91 (−11.61%)
Jun 2, 2026
17w ago
144
NEUTRAL ★ 2/10
$34.45 $45.15▲ +31.06%▲ +32.62%$39.91 (+15.85%)
May 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.87 $38.46▲ +10.30%▲ +8.71%$39.91 (+14.45%)
May 7, 2026
21w ago
8-K
BULLISH ★ 7/10
$35.13 $34.74▼ −1.11%▼ −4.25%$39.91 (+13.61%)
May 7, 2026
21w ago
Press Release
BULLISH ★ 8/10
$35.13 $34.74▼ −1.11%▼ −4.25%$39.91 (+13.61%)
Apr 23, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$34.40 $35.40▲ +2.91%▼ −1.73%$39.91 (+16.02%)
Mar 19, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$32.74 $35.68▲ +8.98%▲ +1.36%$39.91 (+21.90%)
Showing 10 of 12

US Market Status

Market Open — Closes in 2h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access